Company: DVAX
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001628280-25-049536
Chunk: 206

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-11-05
Form: 10-Q
Item: Part II, Item 2
Chunk 206
---
ITEM 2.             UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 

          None. 

ITEM 3.             DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.             MINE SAFETY DISCLOSURES

None.

ITEM 5.             OTHER INFORMATION

During the three months ended September 30, 2025, none of our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Item 408 of Regulation S-K.

73

Table of Contents

ITEM 6.             EXHIBITS

  Incorporated by Reference ExhibitNumberDocumentExhibitNumberFilingFiling DateFile No.Filed Herewith3.1Restated Certificate of Incorporation3.18-KJune 17, 2025001-34207 3.2Amended and Restated Bylaws3.28-KJune 17, 2025001-34207 4.1Reference is made to Exhibits 3.1 and 3.2    4.2Form of Specimen Common Stock Certificate4.2S-1/AJanuary 16, 2004333-109965 4.3Indenture between Company and U.S. Bank National Association, as trustee, dated May 13, 20214.18-KMay 13, 2021 001-34207  4.4Form of Global Note, representing Dynavax Technologies Corporation’s 2.50% Convertible Senior Notes due 20264.28-KMay 13, 2021001-34207 4.5Indenture, dated as of March 13, 2025, between Company and U.S. Bank Trust Company, National Association, as Trustee4.18-KMarch 13, 2025001-342074.6Form of 2.00% Convertible Senior Notes due 2030 (included as Exhibit A to Exhibit 4.6)4.28-KMarch 13, 2025001-3420731.1Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002    X31.2Cert